Efficacy and Safety of Postoperative Stereotactic Radiotherapy to the Prostate Bed (Long-Term Follow-Up Results)
Authors:
- Никита Олегович КузнецовНКНикита Олегович Кузнецов
- Роман Владимирович НовиковРНРоман Владимирович Новиков
- Сергей Николаевич НовиковСНСергей Николаевич Новиков
- Екатерина Евгеньевна СамарцеваЕСЕкатерина Евгеньевна Самарцева
- Николай Дмитриевич ИльинНИНиколай Дмитриевич Ильин
- Иван Георгиевич ГафтонИГИван Георгиевич Гафтон
- Юрий Олегович МережкоЮМЮрий Олегович Мережко
- Филипп Евгеньевич АнтиповФАФилипп Евгеньевич Антипов
- Мария Юрьевна ГотовчиковаМГМария Юрьевна Готовчикова
- Юлия Сергеевна МельникЮМЮлия Сергеевна Мельник
- Ольга Игоревна ПономареваОПОльга Игоревна Пономарева
- Сергей Васильевич КанаевСКСергей Васильевич Канаев
Open Access
- 5 November 2025
- journal article
- Published by Autonomous non-profit scientific and medical organization - Questions of Oncology in Voprosy onkologii
- Vol. 71 (5)
Abstract
Introduction. Despite advances in the surgical management of prostate cancer (PCa), postoperative recurrence remains a significant clinical challenge. Contemporary approaches to postoperative radiation therapy, including stereotactic body radiation therapy (SBRT), offer promising opportunities to enhance therapeutic efficacy and reduce treatment duration while maintaining an acceptable toxicity profile. Aim. To evaluate the long-term efficacy and safety of postoperative SBRT directed to the prostate bed (PB) in patients with recurrent PCa following radical prostatectomy (RP). Materials and Methods. A prospective single-center study enrolled 56 patients with biochemical recurrence of PCa after RP. All patients received SBRT to the PB with a total dose of 35 Gy delivered in five fractions. The median follow-up duration was 38 months. Oncological outcomes, radiation-induced toxicity (assessed using RTOG criteria), and quality of life parameters were evaluated. Results. Biochemical recurrence occurred in 13 patients (23.2 %), including three cases (5.4 %) of local relapse within the PB. Disease-free survival was maintained in 76.8 % of patients at the final follow-up, with local control achieved in 94.6 % of cases. Acute grade I genitourinary toxicity was observed in 11 patients (19.6 %). Late toxicities included grade I–II genitourinary effects in 25 patients (44.6 %) and grade I–II gastrointestinal effects in five patients (8.9 %). No grade III or higher radiation-related complications were reported. Quality of life measures remained stable compared to baseline values. Conclusion. Postoperative SBRT targeting the PB provides excellent local control and is well tolerated. This treatment approach represents an effective and safe therapeutic option for patients with recurrent PCa following surgical intervention.Keywords
This publication has 30 references indexed in Scilit:
- EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer—2024 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative IntentEuropean Urology, 2024
- Toxicity profile and Patient-Reported outcomes following salvage Stereotactic Ablative Radiation Therapy to the prostate Bed: The POPART multicentric prospective studyClinical and Translational Radiation Oncology, 2023
- ESTRO ACROP guideline on prostate bed delineation for postoperative radiotherapy in prostate cancerClinical and Translational Radiation Oncology, 2023
- EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer—2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative IntentEuropean Urology, 2021
- Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology, 2020
- Management Options for Biochemically Recurrent Prostate CancerCurrent Treatment Options in Oncology, 2017
- Early Salvage Radiotherapy Following Radical ProstatectomyEuropean Urology, 2014
- Development of RTOG Consensus Guidelines for the Definition of the Clinical Target Volume for Postoperative Conformal Radiation Therapy for Prostate CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2010
- Anatomic Boundaries of the Clinical Target Volume (Prostate Bed) After Radical ProstatectomyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2007
- Natural History of Biochemical Recurrence after Radical Prostatectomy: Risk Assessment for Secondary TherapyEuropean Urology, 2007